These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 19585299)

  • 1. Audit of antipsychotic polypharmacy in Christchurch.
    McKean A; Vella-Brincat J
    Australas Psychiatry; 2009 Aug; 17(4):336-7. PubMed ID: 19585299
    [No Abstract]   [Full Text] [Related]  

  • 2. Are there any news about the antipsychotic medications in the elderly?
    Cucinotta D; Minardi M; Lanfranchi G; Reggiani A; Savorani G
    Arch Gerontol Geriatr; 2007; 44 Suppl 1():133-7. PubMed ID: 17317446
    [TBL] [Abstract][Full Text] [Related]  

  • 3. When less is more: reducing the incidence of antipsychotic polypharmacy.
    Tucker WM
    J Psychiatr Pract; 2007 May; 13(3):202-4. PubMed ID: 17522566
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antipsychotic polypharmacy: do benefits justify the risks?
    Tapp AM; Wood AE; Kilzieh N; Kennedy A; Raskind MA
    Ann Pharmacother; 2005 Oct; 39(10):1759-60. PubMed ID: 16144885
    [No Abstract]   [Full Text] [Related]  

  • 5. The DEBIT trial: an intervention to reduce antipsychotic polypharmacy prescribing in adult psychiatry wards - a cluster randomized controlled trial.
    Thompson A; Sullivan SA; Barley M; Strange SO; Moore L; Rogers P; Sipos A; Harrison G
    Psychol Med; 2008 May; 38(5):705-15. PubMed ID: 17825122
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The CATIE study and its implications for antipsychotic drug use.
    Janicak PG
    Essent Psychopharmacol; 2006; 7(1):53-63. PubMed ID: 16989293
    [No Abstract]   [Full Text] [Related]  

  • 7. Antipsychotic polypharmacy: squandering precious resources?
    Stahl SM
    J Clin Psychiatry; 2002 Feb; 63(2):93-4. PubMed ID: 11874226
    [No Abstract]   [Full Text] [Related]  

  • 8. Antipsychotic polypharmacy does not increase the risk for side effects.
    Ganesan S; Taylor R; Rabheru K; Forbes I; Dumontet J; Procyshyn RM
    Schizophr Res; 2008 Jan; 98(1-3):323-4. PubMed ID: 17950576
    [No Abstract]   [Full Text] [Related]  

  • 9. Antipsychotic polypharmacy, part 2: tips on use and misuse.
    Stahl SM
    J Clin Psychiatry; 1999 Aug; 60(8):506-7. PubMed ID: 10498453
    [No Abstract]   [Full Text] [Related]  

  • 10. Monotherapy versus polypharmacy for hospitalized psychiatric patients.
    Case BG; Patrick L; Peselow ED
    Am J Psychiatry; 2005 Mar; 162(3):632; author reply 632-3. PubMed ID: 15741498
    [No Abstract]   [Full Text] [Related]  

  • 11. Monotherapy versus polypharmacy for hospitalized psychiatric patients.
    Citrome L; Jaffe A; Levine J
    Am J Psychiatry; 2005 Mar; 162(3):631; author reply 632-3. PubMed ID: 15741497
    [No Abstract]   [Full Text] [Related]  

  • 12. Antipsychotic polypharmacy at admission predicts extended length of stay among state hospital inpatients.
    Lacasse JR
    Aust N Z J Psychiatry; 2014 Nov; 48(11):1065. PubMed ID: 24835210
    [No Abstract]   [Full Text] [Related]  

  • 13. Observations on neuroleptic use in acutely psychotic patients.
    Kirkpatrick B; Burnett GB
    J Clin Psychopharmacol; 1982 Jun; 2(3):205-7. PubMed ID: 6124559
    [No Abstract]   [Full Text] [Related]  

  • 14. Antipsychotic polypharmacy in older Australians.
    Kalisch Ellett LM; Pratt NL; Kerr M; Roughead EE
    Int Psychogeriatr; 2018 Apr; 30(4):539-546. PubMed ID: 29122047
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Neuroleptics. Principles and rules of their utilization].
    Abadie P; Dollfus S
    Rev Prat; 1999 Dec; 49(19):2135-44. PubMed ID: 10649650
    [No Abstract]   [Full Text] [Related]  

  • 16. Use of survival curves in analysis of antipsychotic relapse studies.
    Davis JM; Dysken MW; Haberman SJ; Javaid JI; Chang SS; Killian GA
    Adv Biochem Psychopharmacol; 1980; 24():471-81. PubMed ID: 6105794
    [No Abstract]   [Full Text] [Related]  

  • 17. Antipsychotic polypharmacy: evidence based or eminence based?
    Stahl SM
    Acta Psychiatr Scand; 2002 Nov; 106(5):321-2. PubMed ID: 12366464
    [No Abstract]   [Full Text] [Related]  

  • 18. Switching antipsychotics. Antipsychotic tolerance, withdrawal and relapse: unresolved issues and research implications.
    Goudie AJ; Cole JC
    J Psychopharmacol; 2008 Sep; 22(7):815-7. PubMed ID: 18753274
    [No Abstract]   [Full Text] [Related]  

  • 19. A pilot study testing a medication algorithm to reduce polypharmacy.
    Mistler LA; Mellman TA; Drake RE
    Qual Saf Health Care; 2009 Feb; 18(1):55-8. PubMed ID: 19204133
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroleptic drug usage. (Continued education).
    Holt RJ
    J Pract Nurs; 1983 Mar; 33(3):28-35. PubMed ID: 6132003
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.